Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Advanced Thyroid Cancer

Recent Patents on Anti-cancer Drug Discovery
Emanuela VaccherCarlo Gobitti

Abstract

Thyroid cancer is the most common endocrine neoplasia and represents approximately 1.5% to 2.1% of all cancers diagnosed annually worldwide. Iodine refractory differentiated thyroid carcinoma (RR-DTC) and advanced/metastatic medullary thyroid carcinoma are relatively uncommon yet prognostically significant thyroid cancers. Gene rearrangements resulting in the aberrant activity of tyrosine kinases have been identified as drivers of oncogenesis in a variety of cancers, including thyroid cancer. Many Multi-Kinase Inhibitors (MKIs) which are now FDA-/EMA-approved for thyroid cancer have shown clinical benefit in patients with advanced cancer. Treatment-related toxicities occur frequently with these drugs and can be severe or life-threatening. This review summarizes the role of targeted therapy with MKIs in the management of RR-DTC and advanced/metastatic MTC patients, focusing on side-effect profiles of these drugs, with a presentation of several recent patents published in this field. We review the scientific literature about advanced thyroid cancer and we analyze the International Pharmacovigilance database (FAERS, Eudravigilance, and WHO Vigibase) for adverse drug reactions. This systematic analysis highlights the difference of ...Continue Reading

References

Dec 2, 2008·Best Practice & Research. Clinical Endocrinology & Metabolism·James A Fagin, Nicholas Mitsiades
Dec 24, 2008·Nature Reviews. Cancer·Jianming ZhangNathanael S Gray
Oct 26, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Samuel A WellsMartin J Schlumberger
Jun 8, 2013·The Journal of Clinical Endocrinology and Metabolism·Samuel A WellsMassimo Santoro
Sep 5, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rossella EliseiSteven I Sherman
Nov 22, 2013·The Annals of Pharmacotherapy·Maryann R CooperMichael Steinberg
Jun 15, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nicolas WidmerAlain Astier
Aug 8, 2014·Thyroid : Official Journal of the American Thyroid Association·Maria E CabanillasSteven I Sherman
Nov 5, 2014·Therapeutic Advances in Medical Oncology·Francis Worden
Feb 12, 2015·The New England Journal of Medicine·Martin SchlumbergerSteven I Sherman
Jul 15, 2015·Recent Patents on Anti-cancer Drug Discovery·Poupak FallahiAlessandro Antonelli
Jul 15, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David S HongJohn Nemunaitis
Oct 21, 2015·Expert Opinion on Drug Safety·Jolanta KrajewskaBarbara Jarzab
Dec 19, 2015·Cancer Treatment Reviews·Maria E Cabanillas, Mouhammed Amir Habra
Feb 16, 2016·The Journal of Clinical Investigation·Iñigo LandaJames A Fagin
Jun 15, 2016·Expert Opinion on Drug Safety·Venessa H M TsangDiana L Learoyd
Oct 13, 2016·The New England Journal of Medicine·Javid J Moslehi
Apr 1, 2017·JAMA : the Journal of the American Medical Association·Hyeyeun LimCari M Kitahara
Jun 15, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marcia S BroseArti Hurria
Aug 19, 2017·Cancer Treatment Reviews·Matteo SantoniRossana Berardi
Aug 26, 2017·The Journal of Endocrinology·Miguel A Zaballos, Pilar Santisteban
Sep 16, 2017·Best Practice & Research. Clinical Endocrinology & Metabolism·Furio Pacini
Sep 16, 2017·Best Practice & Research. Clinical Endocrinology & Metabolism·Valentina De FalcoMassimo Santoro
Sep 16, 2017·Best Practice & Research. Clinical Endocrinology & Metabolism·Antonio MatroneRossella Elisei
Oct 11, 2017·Nature Reviews. Clinical Oncology·Peter Sidaway
Oct 19, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M SchlumbergerS Sherman
Mar 20, 2018·Otolaryngologic Clinics of North America·Anastasios ManiakasMark E Zafereo
Apr 5, 2018·Cancers·Allison M Lange, Hui-Wen Lo
Apr 14, 2018·Critical Reviews in Oncology/hematology·Yuchen JinLibo Chen
Apr 19, 2018·Current Pharmaceutical Biotechnology·Androulla N Miliotou, Lefkothea C Papadopoulou
Apr 29, 2018·Cancer Treatment Reviews·Marcia S BroseRobert Haddad
Oct 12, 2018·Drugs of Today·V R AgrawalD W Bowles
Jan 4, 2019·Chronic Diseases and Translational Medicine·Xiao HanWei-Dong Han
Nov 1, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M SchlumbergerS Sherman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Thyroid : Official Journal of the American Thyroid Association
Anastasios GkountouvasPhilippos Kaldrimidis
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Lei YeRobert F Gagel
Cancer Causes & Control : CCC
Eva NegriJoseph F Fraumeni
© 2021 Meta ULC. All rights reserved